Disruption of the lung structure maintenance programme: A comprehensive view of emphysema development

European Respiratory Journal

Volumn 37, Issue 4, 2011, Pages 752-754

  Barbera J A ^a,b   Peinado, V I ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

APOPTOSIS; ARTERIAL GAS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; DISEASE SEVERITY; EDITORIAL; ENDOTHELIUM CELL; ENVIRONMENTAL EXPOSURE; EPITHELIUM CELL; GAS EXCHANGE; GENETIC ASSOCIATION; HUMAN; IMMUNE RESPONSE; LUNG ALVEOLUS EPITHELIUM; LUNG EMPHYSEMA; LUNG ENDOTHELIUM; LUNG STRUCTURE; MACROPHAGE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENESCENCE;

ANIMALS; APOPTOSIS; EMPHYSEMA; GENE EXPRESSION REGULATION; HUMANS; LUNG; MODELS, BIOLOGICAL; MODELS, GENETIC; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE; RATS;

EID: 79953692679     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00154610     Document Type: Editorial

References (30)

1. Gross P, Babyak MA, Tolker E, et al. Enzymatically produced pulmonary emphysema; a preliminary report. J Occup Med 1964; 6: 481-484.
2. Eriksson S. Pulmonary emphysema and a1-antitrypsin deficiency. Acta Med Scand 1964; 175: 197-205.
3. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008; 31: 1334-1356.
4. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 258-266. (Pubitemid 41566933)
5. Shapiro SD. Vascular atrophy and VEGFR-2 signaling: old theories of pulmonary emphysema meet new data. J Clin Invest 2000; 106: 1309-1310.
6. Aoshiba K, Nagai A. Senescence hypothesis for the pathogenetic mechanism of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6: 596-601.
7. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360: 2445-2454.
8. Taraseviciene-Stewart L, Voelkel NF. Molecular pathogenesis of emphysema. J Clin Invest 2008; 118: 394-402. (Pubitemid 351206526)
9. Tuder RM, Yoshida T, Fijalkowka I, et al. Role of lung maintenance program in the heterogeneity of lung destruction in emphysema. Proc Am Thorac Soc 2006; 3: 673-679. (Pubitemid 44788223)
10. Calabrese F, Giacometti C, Beghe B, et al. Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. Respir Res 2005; 6: 14.
11. Hodge S, Hodge G, Holmes M, et al. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J 2005; 25: 447-454. (Pubitemid 40331174)
12. Kasahara Y, Tuder RM, Cool CD, et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001; 163: 737-744. (Pubitemid 32230838)
13. Voelkel NF, Vandivier RW, Tuder RM. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 2006; 290: L209-L221.
14. Thaikoottathil JV, Martin RJ, Zdunek J, et al. Cigarette smoke extract reduces VEGF in primary human airway epithelial cells. Eur Respir J 2009; 33: 835-843.
15. Marwick JA, Stevenson CS, Giddings J, et al. Cigarette smoke disrupts VEGF165-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: morphological impact of VEGFR-2 inhibition. Am J Physiol Lung Cell Mol Physiol 2006; 290: L897-L908. (Pubitemid 43725052)
16. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106: 1311-1319.
17. Tang K, Rossiter HB, Wagner PD, et al. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol 2004; 97: 1559-1566. (Pubitemid 39299378)
18. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, et al. An animal model of autoimmune emphysema. Am J Respir Crit Care Med 2005; 171: 734-742. (Pubitemid 40471144)
19. Yasuo M, Mizuno S, Kraskauskas D, et al. Hypoxia inducible factor-1a in human emphysema lung tissue. Eur Respir J 2011; 37: 775-783.
20. Semenza GL. Pulmonary vascular responses to chronic hypoxia mediated by hypoxia-inducible factor 1. Proc Am Thorac Soc 2005; 2: 68-70. (Pubitemid 40562965)
21. Mie LY, Kim SH, Kim HS, et al. Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1a activity. Biochem Biophys Res Commun 2003; 300: 241-246.
22. Siganaki M, Koutsopoulos AV, Neofytou E, et al. Deregulation of apoptosis mediators p53 and bcl2 in lung tissue of COPD patients. Respir Res 2010; 11: 46.
23. Adenuga D, Yao H, March TH, et al. Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. Am J Respir Cell Mol Biol 2009; 40: 464-473.
24. Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005; 352: 1967-1976. (Pubitemid 40638367)
25. Adcock IM, Cosio B, Tsaprouni L, et al. Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response. Antioxid Redox Signal 2005; 7: 144-152. (Pubitemid 40187932)
26. Liu B, Chen Y, St Clair DK. ROS and p53: a versatile partnership. Free Radic Biol Med 2008; 44: 1529-1535.
27. Dehne N, Brune B. HIF-1 in the inflammatory microenvironment. Exp Cell Res 2009; 315: 1791-1797.
28. Ioannou M, Papamichali R, Kouvaras E, et al. Hypoxia inducible factor-1 alpha and vascular endothelial growth factor in biopsies of small cell lung carcinoma. Lung 2009; 187: 321-329.
29. Jatta K, Eliason G, Portela-Gomes GM, et al. Overexpression of von Hippel - Lindau protein in skeletal muscles of patients with chronic obstructive pulmonary disease. J Clin Pathol 2009; 62: 70-76.
30. Santos S, Peinado VI, Ramirez J, et al. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 1250-1256. (Pubitemid 36555098)